Nancyclotep has obtained €7 million in funding and has partnered with PMB to strengthen its position as a reference center for Vectorized Internal Radiation Therapy in France.
Nancyclotep has embarked in a significant investment program to become a reference center for vectorized internal radiation therapy in France… The full media release can be accessed here.
Previous PostIntegration of dynamic parameters in the analysis of 18F-FDopa PET imaging improves the prediction of molecular features of gliomas
Next PostNancyclotep job offer : a technician in animal experimentation on permanent contract within his team
